127 related articles for article (PubMed ID: 19283353)
21. Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.
McMeekin DS; Walker JL; Hartenbach EM; Bookman MA; Koh WJ;
Gynecol Oncol; 2009 Jan; 112(1):134-41. PubMed ID: 18962846
[TBL] [Abstract][Full Text] [Related]
22. Feasibility study of single agent Cisplatin and concurrent radiotherapy in Japanese patients with squamous cell carcinoma of the head and neck: preliminary results.
Zenda S; Onozawa Y; Tahara M; Kawashima M; Shikama N; Sasaki S; Boku N
Jpn J Clin Oncol; 2007 Oct; 37(10):725-9. PubMed ID: 17925299
[TBL] [Abstract][Full Text] [Related]
23. [Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial].
Chen CY; Lu TX; Zhao C; Lu LX; Han F; Sun Y
Ai Zheng; 2007 Apr; 26(4):398-402. PubMed ID: 17430660
[TBL] [Abstract][Full Text] [Related]
24. The role of palliative radiation therapy in symptomatic locally advanced gastric cancer.
Tey J; Back MF; Shakespeare TP; Mukherjee RK; Lu JJ; Lee KM; Wong LC; Leong CN; Zhu M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):385-8. PubMed ID: 17118569
[TBL] [Abstract][Full Text] [Related]
25. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
Ishigami H; Kitayama J; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Hidemura A; Kaisaki S; Nagawa H
Oncology; 2009; 76(5):311-4. PubMed ID: 19299904
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
Sudo K; Yamaguchi T; Ishihara T; Nakamura K; Shirai Y; Nakagawa A; Kawakami H; Uno T; Ito H; Saisho H
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):219-24. PubMed ID: 17189072
[TBL] [Abstract][Full Text] [Related]
28. A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas.
Tedesco KL; Berlin J; Rothenberg M; Choy H; Wyman K; Scott Pearson A; Daniel Beauchamp R; Merchant N; Lockhart AC; Shyr Y; Caillouette C; Chakravarthy B
Radiother Oncol; 2005 Jul; 76(1):54-8. PubMed ID: 15921772
[TBL] [Abstract][Full Text] [Related]
29. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
30. Palliative radiation therapy of symptomatic recurrent bladder cancer.
Yi SK; Yoder M; Zaner K; Hirsch AE
Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350
[TBL] [Abstract][Full Text] [Related]
31. [Three advanced gastric cancer patients successfully treated by combination therapy of paclitaxel and cisplatin].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Katsuta M; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2007 May; 34(5):769-72. PubMed ID: 17496455
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck.
Bottke D; Bathe K; Wiegel T; Hinkelbein W
Strahlenther Onkol; 2007 Mar; 183(3):128-32. PubMed ID: 17340070
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of paclitaxel, cisplatin and 5-fluorouracil combination chemotherapy for unresectable / recurrent gastric cancer.
Kato J; Nagahara A; Iijima K; Kodani T; Higashihara Y; Yoshimura M; Serizawa N; Osada T; Yoshizawa T; Otaka M; Watanabe S
Adv Med Sci; 2010; 55(2):137-42. PubMed ID: 20934959
[TBL] [Abstract][Full Text] [Related]
34. A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors.
Verschraegen CF; Skubitz K; Daud A; Kudelka AP; Rabinowitz I; Allievi C; Eisenfeld A; Singer JW; Oldham FB
Cancer Chemother Pharmacol; 2009 Apr; 63(5):903-10. PubMed ID: 18682950
[TBL] [Abstract][Full Text] [Related]
35. Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors.
Ricart AD; Berlin JD; Papadopoulos KP; Syed S; Drolet DW; Quaratino-Baker C; Horan J; Chick J; Vermeulen W; Tolcher AW; Rowinsky EK; Rothenberg ML
Clin Cancer Res; 2008 Dec; 14(23):7947-55. PubMed ID: 19047127
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.
Mita M; Mita A; Sarantopoulos J; Takimoto CH; Rowinsky EK; Romero O; Angiuli P; Allievi C; Eisenfeld A; Verschraegen CF
Cancer Chemother Pharmacol; 2009 Jul; 64(2):287-95. PubMed ID: 19034451
[TBL] [Abstract][Full Text] [Related]
37. Phase I/IIa study of combination chemotherapy with CKD-602 and cisplatin in patients with recurrent epithelial ovarian cancer.
Kim HS; Kang SB; Seo SS; Han SS; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():627-34. PubMed ID: 19723113
[TBL] [Abstract][Full Text] [Related]
38. [A phase I study of intraperitoneal plus intravenous paclitaxel against gastric cancer with peritoneal dissemination (HGCG 0301)].
Shinohara H; Okamoto S; Nishitai R; Shirakata Y; Itoi K; Yamagami K; Taki Y; Yamamoto M; Mizuno Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2027-31. PubMed ID: 17197747
[TBL] [Abstract][Full Text] [Related]
39. Clinical benefit of palliative radiation therapy in advanced gastric cancer.
Kim MM; Rana V; Janjan NA; Das P; Phan AT; Delclos ME; Mansfield PF; Ajani JA; Crane CH; Krishnan S
Acta Oncol; 2008; 47(3):421-7. PubMed ID: 17899453
[TBL] [Abstract][Full Text] [Related]
40. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]